Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 207872

Expand all

CELECOXIB (CELECOXIB)
50MG
Marketing Status: Prescription

Active Ingredient: CELECOXIB
Proprietary Name: CELECOXIB
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 50MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A207872
Product Number: 001
Approval Date: Feb 25, 2020
Applicant Holder Full Name: TIANJIN TIANYAO PHARMACEUTICALS CO LTD
Marketing Status:  Prescription
Patent and Exclusivity Information

CELECOXIB (CELECOXIB)
100MG
Marketing Status: Prescription

Active Ingredient: CELECOXIB
Proprietary Name: CELECOXIB
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 100MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A207872
Product Number: 002
Approval Date: Feb 25, 2020
Applicant Holder Full Name: TIANJIN TIANYAO PHARMACEUTICALS CO LTD
Marketing Status:  Prescription
Patent and Exclusivity Information

CELECOXIB (CELECOXIB)
200MG
Marketing Status: Prescription

Active Ingredient: CELECOXIB
Proprietary Name: CELECOXIB
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 200MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A207872
Product Number: 003
Approval Date: Feb 25, 2020
Applicant Holder Full Name: TIANJIN TIANYAO PHARMACEUTICALS CO LTD
Marketing Status:  Prescription
Patent and Exclusivity Information

CELECOXIB (CELECOXIB)
400MG
Marketing Status: Prescription

Active Ingredient: CELECOXIB
Proprietary Name: CELECOXIB
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 400MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A207872
Product Number: 004
Approval Date: Feb 25, 2020
Applicant Holder Full Name: TIANJIN TIANYAO PHARMACEUTICALS CO LTD
Marketing Status:  Prescription
Patent and Exclusivity Information